⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,736.30
+0.59%
Nasdaq 100
29,588.95
+0.20%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.51
+0.19%
NYSE:TSM
$425.38
+1.23%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,148.68
+0.19%
Brent
$106.67
−2.33%
BTC
$83,065.54
+1.49%
ETH
$2,461.16
+2.33%
DFM General
5,834.65
−0.29%
FTSE ADX
9,829.37
+0.47%
TASI
9,952.06
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,736.30
+0.59%
Nasdaq 100
29,588.95
+0.20%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.58
+0.25%
ADX:IHC
AED 356.60
+1.31%
SAU:2222
SAR 25.48
−1.24%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.51
+0.19%
NYSE:TSM
$425.38
+1.23%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,148.68
+0.19%
Brent
$106.67
−2.33%
BTC
$83,065.54
+1.49%
ETH
$2,461.16
+2.33%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Eli Lilly and Co · News · TradingHolo
Markets
›
United States
› NYSE
› LLY
E
Eli Lilly and Co
NYSE:LLY
Healthcare
CBOE:SPESG
NASDAQ:NQUSLG
$1,240.34
−1.33%
At close
At close · Tue 20 Oct · ≈
AED 4,555.15
· Market cap
$1.17T
· Next earnings
Thu 29 Oct
· Extended
$1,252.66
+0.99%
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
LLY news
Headlines tagged to this company
TR
Eli Lilly and Company (LLY) Wins FDA Label Expansion for Jaypirca in Untreated CLL/SLL
TradingView · 18 d ago
PR
Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL
PR Newswire · 18 d ago
SE
Foghorn extends losses as TD Cowen cuts on Lilly exit
Seeking Alpha · 18 d ago
SE
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
Seeking Alpha · 18 d ago
RE
Major drugmakers turn to China for licensing deals
Reuters · 18 d ago
GU
Lilly Stocks Drop as EloraTZP Beats Zepbound but Tests Tolerability
GuruFocus · 19 d ago
AS
"Patient-centric innovation must be central mission of life sciences industry": JP Nadda at BLSA awards
Asian News International · 19 d ago
DO
How Eli Lilly Just Extended Its Lead in the Weight-Loss Drug Market — Barrons.com
Dow Jones Newswires · 19 d ago
RE
Foghorn to cut 40% of workforce after scrapping Lilly-partnered cancer drug
Reuters · 19 d ago
DO
Eli Lilly's Oral GLP-1 Associated With Reduced Risk of Type 2 Diabetes, Heart Disease in Adults With Obesity
Dow Jones Newswires · 19 d ago
SE
Foghorn plunges as Lilly exits collaboration
Seeking Alpha · 19 d ago
DO
Foghorn Therapeutics Slashes Jobs After Ending Cancer Drug Trials With Ely Lilly
Dow Jones Newswires · 19 d ago
DO
Foghorn to Slash 40% of Jobs as Lilly Cancer Partnership Falls Apart — Barrons.com
Dow Jones Newswires · 19 d ago
SE
Lilly Foundayo is predicted to cut diabetes risk by 57% in late-stage study
Seeking Alpha · 19 d ago
RE
Eli Lilly - Foundayo 17.2 Mg Associated With 57% Reduction In Diabetes Risk, 18% In Cardiovascular Risk Versus Placebo
Reuters · 19 d ago
DO
The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind — WSJ
Dow Jones Newswires · 20 d ago
DO
Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial
Dow Jones Newswires · 20 d ago
RE
Lilly's Foundayo Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction And Weight Loss
Reuters · 20 d ago
← Previous
More news →